Cognitive and functional decline in Huntington's disease: dementia criteria revisited.
about
Sleep and circadian dysfunction in neurodegenerative disorders: insights from a mouse model of Huntington's diseaseSex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington's DiseaseRating scales for behavioral symptoms in Huntington's disease: Critique and recommendations.A two years longitudinal study of a transgenic Huntington disease monkey.DISC1 and Huntington's disease--overlapping pathways of vulnerability to neurological disorder?Phosphorodiamidate morpholino oligomers suppress mutant huntingtin expression and attenuate neurotoxicity.Everyday cognition in prodromal Huntington diseaseDysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington diseaseCognitive impairment in Huntington disease: diagnosis and treatment.Progress and prospects for genetic modification of nonhuman primate models in biomedical research.Identifying Motor, Emotional-Behavioral, and Cognitive Deficits that Comprise the Triad of HD Symptoms from Patient, Caregiver, and Provider Perspectives.The prevalence and causes of younger onset dementia in Eastern Sydney, Australia.The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers.Hereditary chorea - what else to consider when the Huntington's disease genetics test is negative?Antipsychotic drugs in Huntington's disease.What Psychiatrists Should Know about Genes and Alzheimer's Disease.Comparison of cognitive and UHDRS measures in monitoring disease progression in Huntington's disease: a 12-month longitudinal study.Validity of the Montreal Cognitive Assessment in the detection of cognitive dysfunction in Huntington's disease.Participants at the Leiden Site of the REGISTRY Study: A Demographic Approach.Benton Judgment of Line Orientation (JoLO) Test: A Brief and Useful Measure for Assessing Visuospatial Abilities in Manifest, but not Premanifest, Huntington's Disease.Longitudinal pilot-study of Sustained Attention to Response Task and P300 in manifest and pre-manifest Huntington's disease.HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD).Reliability and Validity of the HD-PRO-TriadTM, a Health-Related Quality of Life Measure Designed to Assess the Symptom Triad of Huntington's Disease.Revisiting the neuropsychiatry of Huntington's disease.Rating scales for cognition in Huntington's disease: Critique and recommendations.Progress in developing transgenic monkey model for Huntington's disease.Huntington diseaseCognitive-Motor Interference in Neurodegenerative Disease: A Narrative Review and Implications for Clinical Management
P2860
Q28383062-F56D8E8E-7CEB-441B-B253-6A34BC17655DQ28386809-571716F1-9DAC-4674-AB3A-DAB46E738957Q30249645-E8C41A41-58CD-4674-A30E-576BA90F2EF0Q30577737-8F74D5B6-8850-4DD3-A07D-5E48A9411DCBQ33813559-F0109B69-733D-4DC2-A319-30FCF7E1E405Q34463222-DB9A7B24-2228-49E5-B141-DA61510A0941Q34861585-4277A647-E82D-47D3-B1EE-0FCD03C95462Q36216036-4E631D8C-F597-453E-BCEE-2FF18BCD52EEQ36773397-8EDE9554-EF9D-4F76-80E6-5EBC6BE4713AQ37271259-6F198B43-D55D-4012-9E66-0AE65F1C062CQ37702450-FD650968-E328-459F-9B2D-2450DBBF7CA3Q38259294-4B217BD0-2279-4804-8257-ACE8470E82CEQ38663086-C4AB2929-D278-4B2A-8759-46B43EF9CB4EQ38826931-4E30C558-700A-4CF0-B860-342216040D6EQ38830416-E7F6E915-E2C5-46DA-8866-30A7DF640C01Q41674735-642747C5-7D7D-4558-972E-8590456B608EQ41990962-48761BF1-9BB8-4657-9312-6D110F095B53Q45291627-04D311CB-D858-4BA3-9C1A-28866624395AQ45294016-82040DB0-0C9C-477D-83F9-06C5F609E7C4Q45294018-18648584-0648-467F-B568-6DC5E046601FQ45295494-35E0BBFA-0AB6-4577-AFF4-E01851EF611DQ45296829-BBDECEA1-A916-45E1-9CB7-0AF87F1F2407Q45304624-278E2354-FED6-4106-80FA-57495254D72FQ45305909-C65783FB-EA3B-4D82-B7EF-B0FF90759C93Q47219147-AF28F48F-BAE3-4FA8-BB7F-5CD25EA451C0Q47974512-587C2987-403D-4565-AD72-AFFF08BB764DQ56083219-A1F6E363-811F-469D-B4C0-8BDA65A23B50Q58697865-5A621B44-549C-4805-9040-9FDFE619E84D
P2860
Cognitive and functional decline in Huntington's disease: dementia criteria revisited.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cognitive and functional decline in Huntington's disease: dementia criteria revisited.
@ast
Cognitive and functional decline in Huntington's disease: dementia criteria revisited.
@en
Cognitive and functional decline in Huntington's disease: dementia criteria revisited.
@nl
type
label
Cognitive and functional decline in Huntington's disease: dementia criteria revisited.
@ast
Cognitive and functional decline in Huntington's disease: dementia criteria revisited.
@en
Cognitive and functional decline in Huntington's disease: dementia criteria revisited.
@nl
prefLabel
Cognitive and functional decline in Huntington's disease: dementia criteria revisited.
@ast
Cognitive and functional decline in Huntington's disease: dementia criteria revisited.
@en
Cognitive and functional decline in Huntington's disease: dementia criteria revisited.
@nl
P2093
P2860
P356
P1433
P1476
Cognitive and functional decline in Huntington's disease: dementia criteria revisited.
@en
P2093
Anthony C Gamst
Guerry M Peavy
Joanne M Hamilton
Jody Corey-Bloom
Jody L Goldstein
Mark W Jacobson
Stephanie L Lessig
P2860
P304
P356
10.1002/MDS.22953
P407
P577
2010-07-01T00:00:00Z